**12. Breast implant associated illness**

Although rare, it must be mentioned that there are several cases of Breast Implant illness reported in the literature. As of April 1, 2022 The Food and Drug Administration has received a total of 1130 US and global medical device reports of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) [47]. These cases, must be confirmed by pathology/cytology test or Anaplastic Lymphoma Kinase and CD30 biomarkers. More recently, Sept, 2022, the FDA released a new safety communication about Squamous cell carcinoma and various lymphomas in the capsule around breast implants. The current data is limited but evolving. More studies are required to ascertain the magnitude of these findings. Nonetheless, clinical awareness is paramount [48].
